JP2007533698A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533698A5
JP2007533698A5 JP2007508863A JP2007508863A JP2007533698A5 JP 2007533698 A5 JP2007533698 A5 JP 2007533698A5 JP 2007508863 A JP2007508863 A JP 2007508863A JP 2007508863 A JP2007508863 A JP 2007508863A JP 2007533698 A5 JP2007533698 A5 JP 2007533698A5
Authority
JP
Japan
Prior art keywords
glucocorticoids
items
item
hours
released
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007508863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533698A (ja
JP5149618B2 (ja
Filing date
Publication date
Priority claimed from SE0401031A external-priority patent/SE0401031D0/xx
Application filed filed Critical
Publication of JP2007533698A publication Critical patent/JP2007533698A/ja
Publication of JP2007533698A5 publication Critical patent/JP2007533698A5/ja
Application granted granted Critical
Publication of JP5149618B2 publication Critical patent/JP5149618B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007508863A 2004-04-22 2005-04-21 グルココルチコイド代償療法用の医薬組成物 Expired - Lifetime JP5149618B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US56420504P 2004-04-22 2004-04-22
SE0401031A SE0401031D0 (sv) 2004-04-22 2004-04-22 A new glucocorticoid replacement therapy
SE0401031-0 2004-04-22
US60/564,205 2004-04-22
PCT/EP2005/004400 WO2005102271A2 (en) 2004-04-22 2005-04-21 Pharmaceutical compositions for glucocorticoid replacement therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012173158A Division JP5681679B2 (ja) 2004-04-22 2012-08-03 グルココルチコイド代償療法用の医薬組成物

Publications (3)

Publication Number Publication Date
JP2007533698A JP2007533698A (ja) 2007-11-22
JP2007533698A5 true JP2007533698A5 (https=) 2012-03-22
JP5149618B2 JP5149618B2 (ja) 2013-02-20

Family

ID=35197481

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007508863A Expired - Lifetime JP5149618B2 (ja) 2004-04-22 2005-04-21 グルココルチコイド代償療法用の医薬組成物
JP2012173158A Expired - Lifetime JP5681679B2 (ja) 2004-04-22 2012-08-03 グルココルチコイド代償療法用の医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012173158A Expired - Lifetime JP5681679B2 (ja) 2004-04-22 2012-08-03 グルココルチコイド代償療法用の医薬組成物

Country Status (25)

Country Link
US (3) US8425937B2 (https=)
EP (2) EP3072507B1 (https=)
JP (2) JP5149618B2 (https=)
CN (2) CN1942176B (https=)
AU (1) AU2005235370B2 (https=)
BR (1) BRPI0510044B8 (https=)
CA (1) CA2564000C (https=)
CY (2) CY1118275T1 (https=)
DK (2) DK1744730T3 (https=)
ES (2) ES2857600T3 (https=)
HR (2) HRP20161380T1 (https=)
HU (2) HUE053248T2 (https=)
IL (2) IL178776A (https=)
LT (2) LT3072507T (https=)
ME (1) ME02584B (https=)
MX (2) MX344197B (https=)
NZ (1) NZ585340A (https=)
PL (2) PL1744730T3 (https=)
PT (2) PT1744730T (https=)
RS (2) RS55198B1 (https=)
SE (1) SE0401031D0 (https=)
SG (1) SG188081A1 (https=)
SI (1) SI3072507T1 (https=)
WO (1) WO2005102271A2 (https=)
ZA (1) ZA200609680B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533697A (ja) 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
EP1971312A1 (en) * 2005-12-06 2008-09-24 MonoSol Rx LLC Topical film compositions for delivery of actives
FR2926722B1 (fr) * 2008-01-25 2010-09-03 Substipharm Dev Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone
ES2358158T3 (es) * 2008-07-21 2011-05-06 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento del tracto digestivo superior.
NZ595428A (en) * 2009-04-07 2013-04-26 Duocourt Pharma Ab Improved glucocorticoid therapy
PE20131024A1 (es) 2010-05-20 2013-10-10 Duocort Pharma Ab Composiciones basadas en glucocorticoides
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201202433D0 (en) * 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
JP2014086673A (ja) 2012-10-26 2014-05-12 Mitsubishi Electric Corp モノリシック集積回路
JP6356684B2 (ja) 2012-11-02 2018-07-11 マレイ・アンド・プール・エンタープライゼズ・リミテッド コルヒチン誘導体の投与による心血管イベントの処置または予防
DK2986280T3 (da) * 2013-04-16 2021-06-14 Murray & Poole Entpr Ltd Formuleringer med langvarig frigivelse af colchicin og fremgangsmåder til brug af samme
CA2909370A1 (en) * 2013-04-16 2014-10-23 Murray And Poole Enterprises Limited Sustained-release formulations of colchicine and methods of using same
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
PT2886108T (pt) 2013-12-23 2019-04-01 Dr Falk Pharma Gmbh Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago
WO2016160969A1 (en) 2015-03-30 2016-10-06 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
CN107115308B (zh) * 2016-02-23 2021-02-23 天津金耀集团有限公司 一种氢化可的松双相缓释片剂组合物
RU2748437C2 (ru) * 2019-10-28 2021-05-25 Федеральное государственное бюджетное учреждение науки Институт цитологии Российской академии наук (ИНЦ РАН) Производное гидрокортизона в качестве средства для лечения болезни Альцгеймера
FR3116439B1 (fr) * 2020-11-26 2023-08-04 Laboratoire Dielen Comprimé pelliculé contenant au moins un principe actif, adapté à l’administration par voie orale dudit au moins un principe actif chez des sujets humains
WO2026052804A1 (en) 2024-09-06 2026-03-12 Institut National de la Santé et de la Recherche Médicale Hydrocortisone based oral dispersible film and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2260384C3 (de) * 1972-12-09 1979-11-29 Hoechst Ag, 6000 Frankfurt Oral zu applizierendes Corticosteroid-Präparat
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
ATE253899T1 (de) 1994-01-31 2003-11-15 Yamanouchi Pharma Co Ltd Intraoral löslicher formpressling und verfahren zu seiner herstellung
US5534263A (en) 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19718012C1 (de) 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6500459B1 (en) 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
US6156743A (en) 1999-10-18 2000-12-05 Whitcomb; John E. Method of decreasing fatigue
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AP1748A (en) * 2001-03-13 2007-06-11 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms.
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
GB0119848D0 (en) 2001-08-15 2001-10-10 Univ Sheffield Delayed and sustained drug release
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
WO2003066029A2 (en) 2002-02-07 2003-08-14 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery
GB0400031D0 (en) 2004-01-03 2004-02-04 Univ Sheffield Depression treatment
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
JP2007533697A (ja) 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
GB0623740D0 (en) 2006-11-28 2007-01-10 Diurnal Ltd Treatment of disease
NZ595428A (en) 2009-04-07 2013-04-26 Duocourt Pharma Ab Improved glucocorticoid therapy
PE20131024A1 (es) 2010-05-20 2013-10-10 Duocort Pharma Ab Composiciones basadas en glucocorticoides

Similar Documents

Publication Publication Date Title
JP2007533698A5 (https=)
JP5681679B2 (ja) グルココルチコイド代償療法用の医薬組成物
EP3548014B1 (en) Ketamine for the treatment of menstrually related symptoms
CA2757858C (en) Improved glucocorticoid therapy
CA2563609A1 (en) Pharmaceutical compositions for acute glucocorticoid therapy
US20070149465A1 (en) Compositions and methods for prevention and treatment of cachexia
JP6566638B2 (ja) メサラミンの放出制御固形製剤
US20190160150A1 (en) Acth for treatment of acute respiratory distress syndrome
WO2008122190A1 (en) The composition comprising l-carnitine or derivatives thereof and its use
RS52912B (sr) Novi oblik administracije racecadotrila
KR20200040761A (ko) 코티코트로핀 방출 인자 수용체 길항제
US20140329782A1 (en) Combined therapeutic agent
US20060004076A1 (en) Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
RU2619869C2 (ru) Композиция гидрокортизона с контролируемым высвобождением
US20120245552A1 (en) Combination Therapy
JP2019532112A (ja) 結節性痒疹の治療方法
JP2011506607A5 (https=)
CN112494461A (zh) 一种美沙拉嗪肠溶缓释药物组合物及制备方法
JP7033454B2 (ja) Ａｅｒｄ／喘息におけるトロンボキサン受容体拮抗薬
DK1744760T3 (en) PHARMACEUTICAL COMPOSITIONS FOR ACUTE glucocorticoid
EP1100481B1 (en) Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
TW201212907A (en) Inhaled combination product for asthma
HK1167103B (en) Improved glucocorticoid therapy
HK1167103A (en) Improved glucocorticoid therapy
JP2013056925A (ja) アンドラスト／グルココルチコイドの併用